CNBC contributor and Former Medtronic CEO Bill George reacts to the merger between St. Jude Medical and Abbott Labs. » Read More
What follows is a roundup of corporate earnings reports for Tuesday, Feb. 23.
A source tells CNBC that former President Bill Clinton received two drug-coated stents, called "Xience," made by Abbott Labs.
For the past 7 years, Farr, Miller & Washington has published our Top Ten Stocks for the coming year. The results have been very strong, but we need to be mindful that concentrated positions also concentrate risk.
Stocks rose on Monday, with the Nasdaq hitting a 15-month high buoyed by Internet giant, Amazon.
Goldman recently upgraded the health care sector citing valuations and fundamentals while Wells Fargo downgraded it for the same reasons. Huh?
Stocks declined Tuesday but ended off their lows for the day after the Fed raised its forecast for 2010.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Stocks declined Tuesday, after soaring to new 2009 highs on Monday, as a report showed the economy grew less than expected in the third quarter and HP issued a cautious outlook.
Stocks opened lower Tuesday, after soaring to new 2009 highs on Monday, as a report showed the economy grew less than expected in the third quarter.
What follows is a roundup of corporate earnings reports for Tuesday, Nov. 24.
So far in today's trading session, a total of 31 stocks in the S&P 500 have reached new 52-week highs. Here is a look at those companies.
On Saturday, the House backed a health care bill that would expand coverage to nearly all Americans and bar insurance practices such as refusing to cover people with pre-existing medical conditions. How should investors be positioned? Bob Phillips, managing partner at Spectrum Management Group and Robert Zagunis, co-portfolio manager at Jensen Investment Management shared their insights.
Global stock markets are higher overnight due to...Australia? Yep. The central bank there became the first G20 country to raise interest rates, by 25 basis points to 3.25 points. The Australian dollar jumped to a 14-month high, and stocks rose as well.
A race is on to develop the potentially next big thing in heart surgery: a replacement valve that can be implanted through thin tubes known as catheters rather than by traditional open-heart surgery.
Cramer makes the call on viewers' favorite stocks.
The Lightning Round is extended in this CNBC.com exclusive feature.
Boston Scientific has rallied back to its highest levels since last year's financial crisis and is scheduled to discuss a key defibrillator trial this morning, prompting one large investor to position for a potential decline.
Author Matthew May lays down the gauntlet with this beautiful challenge, "Savvy innovators understand that what isn’t there can often trump what is there."
The market traded sideways on Tuesday with Dow finishing slightly lower and the S&P 500 closing a little higher.
Russia's RTS Index was the first global index to hit the correction stage (down 23 percent since hitting its recent high on June 2nd), but now the MSCI Emerging Markets Index (EEM in its ETF form) is also down double-digits since hitting its recent high on June 1st.